From Trial Expected News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from From Trial Expected. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In From Trial Expected Today - Breaking & Trending Today

Ensysce Biosciences, Inc.: Ensysce Biosciences Announces Completion of Clinical Portion of Human Abuse Potential Trial PF614-103

Published: August 23, 2022

Completion of Clinical Portion Represents Critical Milestone Towards CommercializationNasal Opioid Abuse Being Explored for PF614Data From Trial Expected in September 2022SAN DIEGO, CA / ACCESSWIRE / August

Source: finanznachrichten.de

Related Topics:

United StatesLynn KirkpatrickEnsysce BiosciencesGlen ApseloffShannon DevineOhio Clinical Trials IncEnsysce Biosciences IncMz Group North AmericaEnsysce Biosciences Company ContactOpioid Abuse Being ExploredFrom Trial ExpectedActive Controlled Crossover StudyIntranasal Abuse PotentialImmediate Release OxycodoneNon Dependent Recreational Opioid UserOhio Clinical TrialsAbuse PotentialAbuse DeterrentNily OsmanChief Medical OfficerMaximum Drug LikingTake Drug AgainDrug LikingTrypsin Activated Abuse ProtectionMulti Pill Abuse Resistance

Ensysce Biosciences Announces Completion of Clinical Portion of Human Abuse Potential Trial PF614-103

Published: August 23, 2022

Press release content from Accesswire. The AP news staff was not involved in its creation.

Source: apnews.com

Related Topics:

United StatesLynn KirkpatrickEnsysce BiosciencesGlen ApseloffShannon DevineOhio Clinical Trials IncEnsysce Biosciences IncMz Group North AmericaEnsysce Biosciences Company ContactOpioid Abuse Being ExploredFrom Trial ExpectedActive Controlled Crossover StudyIntranasal Abuse PotentialImmediate Release OxycodoneNon Dependent Recreational Opioid UserOhio Clinical TrialsAbuse PotentialAbuse DeterrentNily OsmanChief Medical OfficerMaximum Drug LikingTake Drug AgainDrug LikingTrypsin Activated Abuse ProtectionMulti Pill Abuse Resistance